What’s in a name? Marijuana, Cannabis, and Hemp

| July 06, 2020 |

Adapted from The Medicalization of Marijuana: Legitimacy, Stigma, and the Patient Experience (Routledge, 2019)  by Michelle Newhart and William Dolphin As with all things involving social controversy, dispute over what to properly call the plant known by the botanical name...

Read more

ASA offers solution to DOJ research block: Our comments on the DEA’s proposed rules

| June 02, 2020 |

On March 23, the Drug Enforcement Administraction (DEA) published a proposed rulemaking—“Controls to Enhance the Cultivation of Marihuana for Research in the United States”—in the Federal Register (85 FR 16292), involving who can grow cannabis in bulk for research purposes.  Americans...

Read more

The Cost of Non-Compliance

| May 08, 2020 |

While most cannabis and hemp businesses understand that they must follow a set of guidelines and implement certain quality control factors into their daily operations, many do not understand the depth of compliance and documentation needed to meet all state...

Read more

5 Ways to Thank Essential Workers

| May 07, 2020 |

While many of us are stuck inside, safe in our homes, most essential workers are still making their commutes into work every day. Whether they’re preparing the food we eat, saving lives in the ICU, delivering packages, or working in...

Read more

Update on Cannabis Rescheduling at the United Nations

| April 27, 2020 |

In March 2020, the United Nations Committee on Narcotic Drugs (CND) was expected to vote on the WHO’s recommendations on the scheduling of cannabis and cannabis products during their annual meeting in Vienna, Austria. However, the CND decided to delay...

Read more

Medical Cannabis Patient Scores Important Victory in Employment Discrimination Lawsuit against Amazon in New Jersey

| April 24, 2020 |

Employment protections for medical cannabis patients in New Jersey could soon be strengthened following an important win for the plaintiff in an employment discrimination lawsuit filed against Amazon last year -- D.J.C. v. Amazon Com DEDC, LLC, et al. The...

Read more

Cannabinoids, Influenza, and Coronavirus

| March 24, 2020 |

With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health. Each person’s health situation...

Read more

Office of Medical Cannabis and Cannabinoid Control: A New Way to End the State/Federal Conflict Regarding Medical Cannabis

| March 09, 2020 |

There are now over 3 million medical cannabis patients across the country; ninety-one percent of Americans now live in states with some form of access to medical cannabis, while sixty-six of American adults are in favor of full legalization. Despite...

Read more

Important Update from USDA

| February 28, 2020 |

The signing of the Agriculture Improvement Act of 2018 (the 2018 Farm Bill) into law resulted in the descheduling of hemp and opened the door to the wide scale production of the crop. It also tasked the United States Department...

Read more

Patient-Focused Recommendations Regarding the Vaping Crisis

| October 01, 2019 |

Update 11/8/2019: The CDC has confirmed that out of 29 samples of lung fluid from affected patients all samples tested positive for Vitamin E acetate. This has led the CDC to consider Vitamin E acetate to be a "chemical of concern." Over...

Read more